Pharmaceutical Executive
Outlining the common data transactions between life sciences companies and the HIPAA-regulated stakeholders they deal with daily-and steps pharma can take to secure and protect its own data.
Shelby Buettner
Advertisement
Shelby Buettner is an associate at McDermott Will & Emery. She advises pharma, medical device, and healthcare companies on FDA regulatory and compliance matters.
Articles by Shelby Buettner
Pharmaceutical Executive
Navigating Data Privacy and Security Considerations in the Life Sciences Industry
Advertisement
Latest Updated Articles
- When HIPAA Doesn’t Apply
October 24th 2017
When HIPAA Doesn’t ApplyNovember 1st 2017
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5